Celltrion Pharm Inc (068760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Celltrion Pharm Inc (068760) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩23.44 Billion ≈ $15.89 Million USD) by net assets (₩426.42 Billion ≈ $288.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review 068760 financial flexibility score to assess the company's free cash flow relative to its total liabilities.

Celltrion Pharm Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Celltrion Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Celltrion Pharm Inc (068760) market capitalisation for the company's overall valuation and market capitalisation.

Celltrion Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celltrion Pharm Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Edifier Technology Co Ltd SHE:002351	0.049x
Collective Mining Ltd TO:CNL	-0.091x
Rio2 Ltd TO:RIO	0.266x
Regis Healthcare Ltd AU:REG	-5.831x
Cosmo Pharmaceuticals N.V F:C43	0.013x
Beijing Creative Distribution Automation Co Ltd SHE:002350	0.034x
Ribo Fashion Group Co Ltd SHG:603196	0.088x
Darbond Technology Co. Ltd. A SHG:688035	N/A

Annual Cash Flow Conversion Efficiency for Celltrion Pharm Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Celltrion Pharm Inc from 2014 to 2024. View Celltrion Pharm Inc (068760) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩396.92 Billion ≈ $268.99 Million	₩56.59 Billion ≈ $38.35 Million	0.143x	+513.25%
2023-12-31	₩376.67 Billion ≈ $255.26 Million	₩8.76 Billion ≈ $5.93 Million	0.023x	+305.01%
2022-12-31	₩356.79 Billion ≈ $241.79 Million	₩-4.05 Billion ≈ $-2.74 Million	-0.011x	-104.04%
2021-12-31	₩331.97 Billion ≈ $224.97 Million	₩93.15 Billion ≈ $63.13 Million	0.281x	+132.68%
2020-12-31	₩300.56 Billion ≈ $203.69 Million	₩36.25 Billion ≈ $24.56 Million	0.121x	+21.24%
2019-12-31	₩280.03 Billion ≈ $189.77 Million	₩27.85 Billion ≈ $18.88 Million	0.099x	+87.67%
2018-12-31	₩270.03 Billion ≈ $183.00 Million	₩14.31 Billion ≈ $9.70 Million	0.053x	+253.13%
2017-12-31	₩293.62 Billion ≈ $198.98 Million	₩-10.16 Billion ≈ $-6.89 Million	-0.035x	+21.58%
2016-12-31	₩344.65 Billion ≈ $233.56 Million	₩-15.21 Billion ≈ $-10.31 Million	-0.044x	-178.02%
2015-12-31	₩236.23 Billion ≈ $160.09 Million	₩13.36 Billion ≈ $9.06 Million	0.057x	-29.99%
2014-12-31	₩214.43 Billion ≈ $145.31 Million	₩17.33 Billion ≈ $11.74 Million	0.081x	--

About Celltrion Pharm Inc

KQ:068760 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.32 Billion

₩1.95 Trillion KRW

Market Cap Rank

#7746 Global

#200 in Korea

Share Price

₩45000.00

Change (1 day)

+1.81%

52-Week Range

₩38000.00 - ₩75700.00

All Time High

₩222138.48